Complications of Diabetes and Obesity - February 24 - March 1, 2009 - Vancouver, British Columbia
Complications of Diabetes and Obesity (J7)
February 24 - March 1, 2009
Fairmont Hotel Vancouver
Vancouver, British Columbia
Sponsored by Pfizer Global Research & Development
Organizers: Ann Marie Schmidt, George L. King and Thomas M. Coffman
Meeting Summary
The complications of diabetes and obesity are emerging as major health problems in the United States and world-wide. Obesity-linked complications may lead to the development of insulin resistance and, ultimately, hyperglycemia. Thus, the study of mechanisms underlying and linking these disorders holds promise for the identification of mechanism-targeted therapeutic agents. In addition to frank and often destructive recruitment of immune responses, diabetes and obesity are significantly modified by host and environment factors. Such factors as hypertension, innate aging, failure of effective pro- or anti- angiogenesis programs, genetic and epigenetic factors may influence the phenotype and outcome in diabetes and obesity. The goals of the meeting will be to integrate these concepts in close collaboration with the “Dissecting the Vasculature” concurrent meeting group. Beginning with the vessel, and addressing superimposed and modifying factors, this program will facilitate greater understanding of mechanisms linked to diabetes and its complications and obesity.
Phone: +1 (800) 253-0685
or +1 (970) 262-1230
Fax: +1 (970) 262-1525
info@keystonesymposia.org
